Mark A. King

35 papers receiving 1.5k citations

Mark A. King's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 430 citations
4300+5+11Years since publication100200300400

Peers

Mark A. King
Comparison fields: 5 of 93
  • Psychiatry and Mental health 397
  • Endocrinology, Diabetes and Metabolism 337
  • Emergency Medicine 93
  • Pediatrics, Perinatology and Child Health 166
  • Epidemiology 273
Replace Richard B. Noto with:
Richard B. Noto United States
Karen Black United States
Arun Kumar Gupta India
I‐Jun Chou Taiwan
A Oliaro Italy
Sobhan Vinjamuri United Kingdom
Florian Masuhr Germany
Michael W. Hanson United States
Soo‐Nyung Kim South Korea
Tom McNicholas United Kingdom
Mark A. King relative to Richard B. Noto United States Richard B. Noto's profile →
Citations per field
00.5×10×12.8×
Richard B. Noto · 1×
Citations per year

Countries citing papers authored by Mark A. King

Since Specialization
Citations

This map shows the geographic impact of Mark A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. King more than expected).

Fields of papers citing papers by Mark A. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. King. The network helps show where Mark A. King may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. King Line = papers co-authored together Mark A. King links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009430
2 1998427
3 2000249
4 201563
5 201149
6 199944
7 200338
8 201532
9 200119
10 199118
11 200316
12 199616
13 200415
14 200215
15 199214
16 201212
17 201411
18 19948
19 19998
20 20048

About Mark A. King

Mark A. King is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Epidemiology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Epilepsy research and treatment (5 papers), Pleural and Pulmonary Diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Metabolism and Genetic Disorders (2 papers), Cardiac tumors and thrombi (2 papers), Cardiac Structural Anomalies and Repair (2 papers) and Myasthenia Gravis and Thymoma (2 papers). The work is most often cited by research in Psychiatry and Mental health (397 citations), Endocrinology, Diabetes and Metabolism (337 citations), Emergency Medicine (93 citations), Pediatrics, Perinatology and Child Health (166 citations) and Epidemiology (273 citations). Mark A. King has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Mark R. Newton, Samuel F. Berkovic, Mervyn J. Silvapulle, Gregory J. Fitt, Graeme D. Jackson, Lex A. Mitchell, Thomas L. Clanton, Mark D. Wewers, Philip T. Diaz and Janice Drake. Their work appears in journals such as Journal of Thoracic Imaging, Academic Radiology, The Medical Journal of Australia, The Annals of Thoracic Surgery and American Journal of Roentgenology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact